Search

everythinglearnresearchcommunity

for

Search:↓

Topical tacrolimus did not regrow hair in alopecia universalis patients.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Fractional laser therapy may help regrow hair in alopecia areata.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

JAK inhibitors show promise as a future treatment for hair loss.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Both treatments for localized alopecia areata are equally effective.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.